Search  

 Pharmaceuticals Business Trends & Latest Market Research

Gene TherapyTargeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the MarketGene Therapy in Oncology Drug Pipeline Update 2011Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical developmentGene Therapy--Industry ImpactU.S. Gene Therapy MarketsWorld Gene Therapy MarketEmerging Developments in Gene Therapy and DNA VaccinesMarket For Gene Therapy and Antisense DrugsPain ManagementTaiwan Anesthesia and Respiratory Devices Market Outlook to 2017- Respiratory Devices, Respiratory Measurement Devices, Airway and Anesthesia Devices, Anesthesia Machines, Sleep Apnea Diagnostic Systems, Pain Management Devices and OthersPain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and CymbaltaPain Management Review and Outlook 2011Transdermal Pain Management to 2015 Markets, Demand Factors, Opportunities and ForecastsU.S. Opioid Pain Management MarketThe Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 - Increasing Generic Competition Creates ChallengesThe Global Market for Pain Management Drugs and DevicesWestern European Pain Management Devices MarketsThe Global Market for Pain Management Drugs and DevicesEuropean Markets for Pain Management DevicesThe Executive Summary: World Market for Pain Management Drugs and Devices, 2nd EditionThe World Market for Pain Management Drugs and Devices: Applications and Top ProductsThe Market for Pain Management Products and ServicesMarketLooks: The U.S. Market for Pain Management PharmaceuticalsAnticoagulantsAnalysis of the Anticoagulant MarketFDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent VTE in Joint Replacement Surgeries in the USThe 2011-2016 World Outlook for Anticoagulant Pharmaceutical PreparationsAcute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary SyndromesAnticoagulants in Stroke Prevention in Atrial Fibrillation (SPAF): Novel Oral Anticoagulants with Superior Safety Profile will Drive the MarketAntithrombotic/Anticoagulant Drugs: World Market Prospects 2010-2025The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)European Coagulation Diagnostics MarketsU.S. Anticoagulant MarketNew Anticoagulant Therapies: A Market BriefingU.S. Anticoagulant Pharmaceutical MarketsBulk PaclitaxelWorld Bulk Paclitaxel MarketsGrowth Factors ( Blood And Tissue )Stakeholder Opinions: Targeting Nerve Growth Factor for Pain TherapyU.S. Blood Growth Factors MarketsGrowth Factor Inhibitors: Markets and Opportunities for a Growing PipelineGrowth Factors: Indications, Products, and MarketsU.S. Growth Factors MarketsOsteoporosis TherapeuticsWomen's Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Osteoporosis MarketOsteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Global Osteoporosis Market & Drugs Analysis 2010 - 2015Postmenopausal Osteoporosis Therapeutics - Pipeline Assessment and Market Forecasts to 2017Post Menopausal Osteoporosis - Pipeline Review, Q2 2011European Women's Health Therapeutics Markets - Urinary Incontinence and OsteoporosisMusculoskeletal Disorders Therapeutics to 2016 - Introduction of Monoclonal Antibodies with First - in - class Mechanism of Action to Increase Treatment Options in Osteoporosis and Rheumatoid ArthritisWomen's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis MarketsPipeline Insight: Osteoporosis - Bone building drugs become the heart of the pipelineCommercial Insight: Osteoporosis - Market players maximize revenue growth before the next challenging phaseOsteoporosis Drugs: Technologies and Global MarketsChinese Markets for Osteoporosis DrugsThe Drug Class Impact of Major Patent ExpirationsTherapeutics and Diagnostics for Women's DisordersU.S. Osteoporosis MarketThe World Market for Prescription Orthopedic DrugsMarketlooks: The World Market for Prescription Osteoporosis DrugsU.S. Emerging Osteoporosis Therapeutics MarketsOvarian Cancer TherapeuticsDoxil/Caelyx (Ovarian Cancer) – Analysis and Forecasts to 2020Ovarian Cancer - Pipeline Review, H1 2012Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug DevelopmentPaclitaxel (Ovarian Cancer) - Analysis and Forecasts to 2020Yondelis (Ovarian Cancer) - Analysis and Forecasts to 2020Ovarian Cancer - Pipeline Review, Q3 2011Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020Chinese Markets for Ovarian Cancer Treatment DrugsU.S. Emerging Ovarian Cancer Therapeutics MarketsWeight Control ProductsU.S. Lipid Regulators MarketsTrends in Weight Management 2011Weight Loss Markets: Products, Services, Foods and BeveragesWeight Management Trends in the U.SFuture Ingredient Trends in Food and Drinks: Growth opportunities in natural, wellness, functional, weight control, exotic products and food safetyNpd In Satiety And Weight Control Food And Drinks: Next Generation Fat Burners, Blockers And Appetite SuppressantsThe U.S. Market for Weight Loss Products and Trends: Moving from Low-Carb to Low-Sugar and Low-Glycemic, 2nd EditionThe U.S. Market for Weight Loss Eating and Product TrendsFat ReplacersFreedonia Focus on Food & Beverage AdditivesThe Food Additives BusinessMarketLooks: The Changing Face of Fat ReplacersGrowth Strategies in IngredientsArtificial Sweetners and Fat ReplacersImmunochemicalsClinical Immunoanalyzer MarketsGlobal Immunochemicals MarketsAnxiety DisordersAnxiety Disorders Therapeutics - Pipeline Assessment and Market Forecasts to 2017Anxiety Disorders Global Clinical Trials Review, Q1, 2011Therapies for Depressive and Anxiety DisordersEndometriosisEndometriosis - Pipeline Review, H2 2011Endometriosis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still neededWomen's Health Series: Endometriosis--How Will New Therapies Compare with Current Market Leaders?European Endometriosis Therapeutics MarketsHerpes Simplex Virus TreatmentHerpes Simplex Infections - Pipeline Review, H2 2011Genital Herpes - Pipeline Review, H2 2011Hormone Replacement Therapy (HRT)Post-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018Bladder Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume 1 2011Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis MarketsPost-Menopausal Hormone Replacement Therapy (HRT) - Pipeline Assessment and Market Forecasts to 2018Opportunities in Menopausal Treatments: Will New Therapies Overtake Hormone Replacement?Hormone Replacement Therapies and Other Hormone Therapies: Global MarketsU.S. Hormone Replacement Therapy MarketsWomen's Reproductive Health 2004DPP IV InhibitorsHot Topics in Type 2 Diabetes: Physician Perceptions of Incretin Mimetics and TZDs ¬- Physician survey provides insights into TZD, DPP-IV, and GLP-1 usageGlobal Diabetes Market Trends & Future Forecast - Diabetes Drug (Anti-Diabetic Drug), Insulin, DPP-IV, GLP-1Type 2 Diabetes Market Dynamics: Impact of Januvia and Other DPP-IV InhibitorsOveractive Bladder (OAB) TherapeuticsOveractive Bladder (OAB) Therapeutics - Pipeline Assessment and Market Forecasts to 2019U.S. Benign Prostatic Hyperplasia MarketsUrinary Tract Agents 2005Pediatric Drugs and VaccinesGlobal Vaccine Market Forecast to 2013Vaccines 2011: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryWorld Influenza Vaccines Market 2011-2021Asian Vaccine Markets: India, China, Japan, Korea, Indonesia and Rest of AsiaWorld Vaccines Market: Vaccine Segments Analysis, Vaccine Cases and Future ForecastEuropean Vaccine Markets: Germany, UK, France, Spain Italy, Rest of EuropeGlobal Vaccine Market Forecast to 2012Vaccines : United StatesVaccines to 2014Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryUS Neonatal (Preterm) Infant Care Market (2010-2015)Global Vaccines Market 2010-2025Chinese Markets for Pediatric DrugsPediatric Drug DeliveryPediatric Health Care Products and ServicesPediatric Drugs: the Worldwide Market, 3rd EditionGlobal Vaccine Market Outlook (2007-2010)Vaccines: The World MarketThe U.S. Market for Over-the-Counter Pediatric Medication and Healthcare ProductsThe Worldwide Market for Pediatric Drugs, 2nd EditionStrategic Analysis of the World Pediatric Pharmaceuticals MarketsThe World Market for Anti-infectives Series: Volumes I - III - Antifungals, Antibacterials and AntiviralsMarketlooks: Pediatric Central Nervous System DrugsThe Worldwide Market for Pediatric DrugsMarketlooks: Pediatric Allergy and Respiratory DrugsMarketlooks: Pediatric Gastrointestinal DrugsMarketLooks: The Market for Pediatric Preventive VaccinesMarket For Pediatric DrugsSepsis TherapeuticsCase Study: Sepsis - Xigris' disappointing performance creates a market opportunity for improved sepsis therapiesSepsis Therapeutics - Pipeline Assessment and Market Forecasts to 2017R&D Trends: Sepsis - Improvements in clinical trial design and advances in biomarker research hold the key to a tailored approach to sepsis therapyMarket for Sepsis Therapeutics and Preventative AgentsBone and Joint Health SupplementsU.S. Bone and Joint Health Ingredients MarketOpportunities in Bone & Joint Health: Consumer Attitudes & BehaviorsNBJ's Joint Health Report 2006Testosterone Replacement Therapy (TRT)Pipeline and Commercial Insight: Testosterone Replacement Therapy - Topical formulations drive market growthTestosterone Replacement Therapy Market ForecastEuropean Testosterone Replacement Therapies MarketsIrritable Bowel Syndrome (IBS) TherapeuticsIrritable Bowel Syndrome Epidemiology by Sub-Type in G7 CountriesNovartis's Zelnorm Suspension - Impact On The Irritable Bowel Syndrome (IBS) Treatment LandscapeIrritable Bowel Syndrome - Pipeline Review, H2 2011Irritable Bowel Syndrome (IBS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Gastrointestinal Disorder Therapeutics Market to 2017 - Crohn's Disease and Irritable Bowel Syndrome Markets Show Strongest GrowthGastrointestinal Disorder Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome MarketsThe World Market for Antidepressants, 2006U.S. Irritable Bowel Syndrome Therapeutics MarketsEuropean Antidepressants MarketsIrritable Bowel Syndrome - Pipeline Review, Q1 2011Kidney Cancer DrugsChinese Markets for Kidney Cancer Treatment DrugsRNA interference (RNAi)Global RNAi Market AnalysisRNAi for Therapeutic Applications: Market Prospects 2011-2021RNAi Drug Delivery: Technologies and Global MarketsDelivering RNAi-Based Therapeutics & Diagnostics: Challenges & OpportunitiesRNA interferenceRNA therapy: the next big thing after monoclonal antibodies?RNA Interference in the Post-Genomic Era: Markets and TechnologiesRealizing the Promise of Therapeutic RNAi: Emerging Strategies for RNAi DeliveryU.S. RNAi MarketsThe Exploding RNAi Market & Future Direction Translating the Genome into a Large Market by 2009The Outlook For RNAi: Accelerating Drug Discovery And The Development Of RNAi TherapeuticsAdvances in RNAi--A Global Technology AssessmentePharmacies - A Global Strategic Business ReportePharmacies: Strategic Implications for the Healthcare IndustryApoptosisTriple Analysis: Leukemia, Apoptosis and AngiogenesisTriple Analysis: Lymphoma, Apoptosis and AngiogenesisTriple Analysis: Melanoma, Apoptosis and AngiogenesisTriple Analysis: Pancreatic Cancer, Apoptosis and AngiogenesisTriple Analysis: Prostate Cancer, Apoptosis and AngiogenesisTriple Analysis: Lung Cancer, Apoptosis and AngiogenesisTriple Analysis: Apoptosis, Angiogenesis and PeptidesTriple Analysis: Apoptosis, Angiogenesis and Cancer VaccinesTriple Analysis: Lymphoma, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Melanoma, Apoptosis and PeptidesTriple Analysis: Apoptosis, Protein Kinase Inhibitors and AntibodiesTriple Analysis: Leukemia, Apoptosis and AntibodiesTriple Analysis: Leukemia, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Lymphoma, Apoptosis and AntibodiesTriple Analysis: Melanoma, Apoptosis and AntibodiesTriple Analysis: Melanoma, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Lymphoma, Apoptosis and Cancer VaccinesTriple Analysis: Lymphoma, Apoptosis and PeptidesTriple Analysis: Apoptosis, Antibodies and PeptidesTriple Analysis: Apoptosis, Cancer Vaccines and AntibodiesTriple Analysis: Apoptosis, Cancer Vaccines and Protein Kinase InhibitorsTriple Analysis: Leukemia, Apoptosis and Cancer VaccinesTriple Analysis: Prostate Cancer, Apoptosis and Cancer VaccinesTriple Analysis: Pancreatic Cancer, Prostate Cancer and ApoptosisTriple Analysis: Pancreatic Cancer, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Lymphoma, Pancreatic Cancer and ApoptosisTriple Analysis: Pancreatic Cancer, Apoptosis and PeptidesTriple Analysis: Breast Cancer, Apoptosis and AntibodiesTriple Analysis: Breast Cancer, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Breast Cancer, Leukemia and ApoptosisTriple Analysis: Breast Cancer, Lung Cancer and ApoptosisTriple Analysis: Breast Cancer, Pancreatic Cancer and ApoptosisTriple Analysis: Colorectal Cancer, Apoptosis and AntibodiesTriple Analysis: Colorectal Cancer, Apoptosis and Cancer VaccinesTriple Analysis: Colorectal Cancer, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Colorectal Cancer, Leukemia and ApoptosisTriple Analysis: Colorectal Cancer, Lung Cancer and ApoptosisTriple Analysis: Colorectal Cancer, Lymphoma and ApoptosisTriple Analysis: Colorectal Cancer, Pancreatic Cancer and ApoptosisTriple Analysis: Colorectal Cancer, Prostate Cancer and ApoptosisTriple Analysis: Leukemia, Lung Cancer and ApoptosisTriple Analysis: Leukemia, Melanoma and ApoptosisTriple Analysis: Lung Cancer, Apoptosis and AntibodiesTriple Analysis: Lung Cancer, Lymphoma and ApoptosisTriple Analysis: Pancreatic Cancer, Apoptosis and Cancer VaccinesTriple Analysis: Prostate Cancer, Apoptosis and AntibodiesTriple Analysis: Melanoma, Prostate Cancer and ApoptosisTriple Analysis: Lymphoma, Melanoma and ApoptosisTriple Analysis: Melanoma, Pancreatic Cancer and ApoptosisTriple Analysis: Prostate Cancer, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Pancreatic Cancer, Apoptosis and AntibodiesTriple Analysis: Lymphoma, Prostate Cancer and ApoptosisTriple Analysis: Breast Cancer, Apoptosis and Cancer VaccinesTriple Analysis: Breast Cancer, Apoptosis and PeptidesTriple Analysis: Breast Cancer, Colorectal Cancer and ApoptosisTriple Analysis: Breast Cancer, Lymphoma and ApoptosisTriple Analysis: Breast Cancer, Melanoma and ApoptosisTriple Analysis: Breast Cancer, Prostate Cancer and ApoptosisTriple Analysis: Colorectal Cancer, Apoptosis and PeptidesTriple Analysis: Colorectal Cancer, Melanoma and ApoptosisTriple Analysis: Leukemia, Lymphoma and ApoptosisTriple Analysis: Leukemia, Pancreatic Cancer and ApoptosisTriple Analysis: Leukemia, Prostate Cancer and ApoptosisTriple Analysis: Lung Cancer, Apoptosis and Cancer VaccinesTriple Analysis: Lung Cancer, Apoptosis and PeptidesTriple Analysis: Lung Cancer, Melanoma and ApoptosisTriple Analysis: Lung Cancer, Pancreatic Cancer and ApoptosisTriple Analysis: Lung Cancer, Prostate Cancer and ApoptosisCompetitive Outlook on Apoptosis in OncologyApoptosis: New Growth OpportunitiesIntravenous (IV) SolutionsThe Infant Nutrition Market in The EU: Key players and market forecasts for clinical nutrition, baby food and baby milkOpportunities and Key Players in Clinical Nutrition: The market for enteral, parenteral and infant nutrition in the US and the EUEuropean IV Therapy and Parenteral Nutritional Solutions MarketsU.S. Intravenous Solution MarketsMarket for Institutional Enteral and Parenteral NutritionalsRegenerative MedicineGlobal Regenerative Medicine MarketTranslational Regenerative Medicine: Market Prospects 2011-2021Future Directions in Regenerative MedicineRegenerative Medicine MarketsStem Cells Market Trends 2010: Drug Discovery/Toxicity Screening and Regenerative MedicineRegenerative Medicines: Bone and Joint ApplicationsStem Cell Therapies and Regenerative Medicine: Current Applications and Future PossibilitiesRegenerative Medicine: Bone and Joint ApplicationsAntidepressantsAnorexia Nervosa Therapeutics - Pipeline Assessment and Market Forecasts to 2018Market and Product Forecasts: Depression – Further clinical failures dampen growth prospectsKey Companies: Depression - Leading players must adapt to remain competitiveThe 2011-2016 World Outlook for Antidepressant PharmaceuticalsThe 2011-2016 World Outlook for Psychotherapeutic Antidepressant AgentsThe 2011-2016 World Outlook for Psychotherapeutic Agents Excluding Tranquilizers and AntidepressantsDepression Market ForecastForecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depressionDealmaking and Industry Outlook: Trends in Psychiatric Disease StrategiesAntidepressants Market ForecastResearch Report On Antidepressant Industry In ChinaCan a New Antidepressant Establish Itself in a Highly Competitive Market?Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World MarketEuropean Antidepressants MarketsThe World Market for Antidepressants, 2006Ophthalmic Pharmaceutical DrugsOphthalmology Therapeutics Market to 2017 - Protein Kinase Inhibitors and Prostaglandin H-Synthase Inhibitors to Drive Diabetic Retinopathy MarketThe Ophthalmic Pharmaceutical Market Outlook to 2016Ophthalmology Drug FuturesOphthalmic Drugs: World Market 2011-2021Dry Eye Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017The Future of Ophthalmology Therapeutics, Analysis and Market Forecasts to 2016 - Strategies to Counter Generic Erosion in Key MarketsGlobal Ophthalmology Devices MarketOphthalmic Therapeutic Drugs: Technologies and Global MarketsWorld Ophthalmic Pharmaceutical Market 2010-2025Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics - 2009-2023World Market for Prescription Generic Drugs, 6th EditionPediatric Drugs: the Worldwide Market, 3rd EditionGlobal Ophthalmic Market Analysis & Forecasts to 2012The U.S. Market for Prescription Ophthalmic Drugs, Devices, Diagnostics, and Surgical EquipmentThe U.S. Market for Prescription Ophthalmic DrugsThe Worldwide Market for Prescription Generic Drugs- 4th EditionRheumatoid Arthritis TherapeuticsThe World Market for Prescription Arthritis Treatments (NSAIDs, DMARDs, BRMs and Immunosuppressants)Rheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Rheumatoid Arthritis - Pipeline Review, H2 2011Rheumatoid Arthritis: World Drug Market 2011-2021Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid ArthritisJuvenile Rheumatoid Arthritis (JRA) Therapeutics - Pipeline Assessment and Market Forecasts to 2017Arthritis Therapeutics Market to 2016 - Biologics Revolutionize Treatment of Rheumatoid Arthritis and Psoriatic ArthritisAutoimmune Treatment (2009 - 2014)The Rheumatoid Arthritis Market Competitive Landscape and Clinical Stage AnalysisRheumatoid Arthritis Therapeutics Market in PhilippinesRheumatoid Arthritis Therapeutics Market in JapanRheumatoid Arthritis Therapeutics Market in ChinaRheumatoid Arthritis Therapeutics Market in ThailandRheumatoid Arthritis Therapeutics Market in IndiaRheumatoid Arthritis Drug Discoveries: What the Future HoldsLatin American Rheumatoid Arthritis Drugs MarketWorldwide Market for Rheumatoid Arthritis and Lupus Treatments ( Autoimmune Disease Markets )Rheumatoid Arthritis: The 45+ Market in the United States for Drugs and BiologicsRheumatoid Arthritis: Emerging Drug Discovery Targets And Therapeutic CandidatesBiological Response ModifiersCancer TherapiesSmall-Molecule Targeted Cancer Therapies: World Market 2011-2021Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-developmentTherapeutic Cancer Vaccines - A New Paradigm in Cancer TherapyOncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the MarketMonoclonal Antibodies in Cancer Therapy: World Market Prospects 2010-2025Biomarker and Diagnostic Opportunities Associated with Targeted Cancer TherapiesPricing and Reimbursement of Targeted Cancer TherapiesThe Targeted Cancer Therapies Pipeline: A Strategic ReviewDealmaking and Industry Outlook: Targeted Cancer TherapiesTargeted Cancer Therapies: Novel Targets, Technologies, and DealmakingMonoclonal Antibodies in Cancer Therapy 2009-2024Issues; Trends and Prevalence in the European Cancer Therapy Market- Non PharmaceuticalCancer Therapies: Technologies and Global MarketsCancer Cell Therapy MarketsDrug Delivery Technologies Revolutionizing Cancer TherapiesCancer Therapies Face Increasing Reimbursement Pressures in Europe and JapanCancer Therapies—Is the United States Always the Most Expensive Market?Targeted Cancer Therapies: Innovative Drugs And Their Impact On The Future Of OncologyImmunomodulators in Cancer Therapy: Emerging Products and MarketsMonoclonal Antibodies in Cancer Therapy: Emerging Products and MarketsU.S. Cancer Support Therapies MarketsThe Global Market for Adjunctive Therapies in CancerMarketLooks: The Antinauseants and Antiemetics Market in Cancer TherapySpecial Package: Current Developments in Immunotherapy Markets and Technology and Advances in Cancer TherapyAdvances in Cancer TherapyMarketLooks: Advances in Cancer TherapyBreast Cancer TherapeuticsTriple Analysis: Breast Cancer, Pancreatic Cancer and AngiogenesisMetastatic Breast Cancer - Pipeline Review, H1 2012Abraxane (Breast Cancer) - Analysis and Forecasts to 2020Triple Analysis: Breast Cancer, Leukemia and ApoptosisBreast Cancer Drug Discoveries: What the Future HoldsBreast Cancer Drug Pipeline Update 2012Breast Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017Breast Cancer Drugs: World Market Prospects 2010-2025Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase InhibitorsChinese Markets for Breast Cancer Treatment DrugsCurrently Druggable in Breast Cancer: A Drug Target Competitive AnalysisU.S. Breast Cancer Therapeutics MarketsAnalytical Tool - Breast Cancer Therapeutics & Competitive InsightsWorld Breast Cancer Therapeutics MarketsStrategic Analysis of the Global Breast Cancer Therapeutics PipelineAsthma TherapeuticsNovel Drug Targets and Strategies for Asthma and Chronic Obstructive Pulmonary DiseaseAsthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Asthma and COPD Therapies: World Market 2011-2021The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016Global Markets for Asthma and COPD DrugsChinese Markets for Asthma Treatment DrugsEuropean Asthma Therapeutics MarketsAsthma and COPD Drug Discoveries: What The Future HoldsAsthma Therapeutics: New Treatment Options And Emerging Drug Discovery TargetsU.S. Asthma Therapies MarketsAsthma Therapeutics MarketAllergy and Asthma TherapeuticsRespiratory DrugsNovel Drug Targets and Strategies for Asthma and Chronic Obstructive Pulmonary DiseaseRespiratory Disorders Therapeutics Market to 2017 - Novel Pipeline Molecules such as VX-770 and pirfenidone May Offset Negative Effect of Patent ExpiriesAsthma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Asthma and COPD Therapies: World Market 2011-2021The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016Respiratory Therapeutics and Devices MarketsThe Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals AnalysisGlobal Markets for Asthma and COPD DrugsChinese Markets for Respiratory DrugsChinese Markets for Asthma Treatment DrugsRespiratory Market Insight 2008European Asthma Therapeutics MarketsThe World Market for Prescription Respiratory DrugsAsthma and COPD Drug Discoveries: What The Future HoldsAsthma Therapeutics: New Treatment Options And Emerging Drug Discovery TargetsU.S. Asthma Therapies MarketsMarketlooks: Prescription Generic Allergy and Respiratory DrugsAsthma Therapeutics MarketAllergy and Asthma TherapeuticsColorectal Cancer TherapeuticsTriple Analysis: Colorectal Cancer, Angiogenesis and Protein Kinase InhibitorsTriple Analysis: Colorectal Cancer, Apoptosis and Protein Kinase InhibitorsTriple Analysis: Colorectal Cancer, Protein Kinase Inhibitors and PeptidesSmall-Molecule Targeted Cancer Therapies: World Market 2011-2021Triple Analysis: Colorectal Cancer, Lung Cancer and Protein Kinase InhibitorsTriple Analysis: Colorectal Cancer, Lymphoma and Protein Kinase InhibitorsTriple Analysis: Colorectal Cancer, Leukemia and Protein Kinase InhibitorsVertex's VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic FibrosisTriple Analysis: Breast Cancer, Colorectal Cancer and Protein Kinase InhibitorsTriple Analysis: Colorectal Cancer, Melanoma and Protein Kinase InhibitorsTargeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the MarketNovel Targeted Therapies Hold Promise of Reversing the Progress of Alzheimer's Disease (AD)Colorectal Cancer - Brazil, China, India and Russia (BRIC) Drug Drug Forecasts and Treatment Analysis to 2020Colorectal Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Q4 2010Colorectal Cancer - US Drug Forecasts and Treatment Analysis to 2020Colorectal Cancer - Pipeline Assessment and Market Forecasts to 2020Biomarker and Diagnostic Opportunities Associated with Targeted Cancer TherapiesPricing and Reimbursement of Targeted Cancer TherapiesThe Targeted Cancer Therapies Pipeline: A Strategic ReviewDealmaking and Industry Outlook: Targeted Cancer TherapiesTargeted Cancer Therapies: Novel Targets, Technologies, and DealmakingChronic Myelogenous Leukemia: New Targeted Therapies Take Aim at GleevecStakeholder Opinions: Gastric Cancer - Targeted therapies compete for first-to-market statusCancer Therapeutics: Market Insight and R&D Pipeline AnalysisOncology Pipelines: Is the Future Targeted Therapy?Histone Deacetylase InhibitorsCardiovascular DrugsAtherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Analysis of Cardiovascular Drugs Market in Saudi Arabia and the United Arab EmiratesThe Cardiovascular Market Outlook to 2016Cardiovascular Therapeutic Drugs: Technologies and Global MarketsChinese Markets for Cardiovascular DrugsGlobal Cardiovascular Drugs Market 2009-2024Protease Inhibitors: Innovation Drives Drug PipelineCardiovascular Drug Discoveries 2008Cardiovascular Generic Drugs: Prospects and Opportunities to 2012The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)Cardiovascular Medicine: Diagnostics, Drugs and DevicesDrug Delivery Technologies Revolutionizing Cardiovascular TherapiesEuropean Cardiovascular Drugs MarketsThe Worldwide Market for Prescription Cardiovascular DrugsCardiovascular Disease: The 45+ Market in the United States for Drugs and Medical DevicesMarketlooks: Prescription Generic Cardiovascular DrugsCardiovascular Drugs: Products, Applications, and New DevelopmentsAlzheimer's And Parkinson's DiseasesParkinson's Disease - Pipeline Review, H1 2012Neurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain GrowthParkinson's Disease: World Drug Market 2011-2021Prescribing Influences: Alzheimer's Disease - Alleviating symptoms remains the goal for prescribersAdvances in Alzheimer's Disease Drug DiscoveryEarly Diagnosis of Alzheimer's Disease - Benefits, Challenges and Recent DevelopmentsThe 10th International Conference on Alzheimer's and Parkinson's Diseases: Post-Conference Review and AnalysisNovel Targeted Therapies Hold the Promise of Cure for Parkinson's Disease (PD)Alzheimer's Disease - Pipeline Review, Q1 2011Epidemiology: Parkinson's DiseaseParkinson's Disease Market ForecastPipeline and Commercial Insight: Parkinson's Disease - Reformulations sustain market growth in the absence of therapeutic breakthroughsEpidemiology: Alzheimer's DiseaseAlzheimer's Disease Market ForecastNeurodegenerative Diseases: World Drug Market 2011-2026Pipeline and Commercial Insight: Alzheimer's Disease - Market cautiously awaits the first generation of disease-modifying therapiesU.S. Alzheimer's Disease Medication MarketAlzheimer's Disease Therapeutics and Diagnostics: Global MarketsWorld Neurodegenerative Diseases Market 2009-2024European Markets for Parkinson's Disease TherapeuticsChinese Markets for Alzheimer Disease DrugsCNS Drug Discoveries: Parkinson's Disease ChapterAlzheimer's Disease Market Analysis and Forecasts, 2007-2012, 2017U.S. Alzheimer's Disease Medications MarketsParkinson's Disease Selections from "The World Market for Neurotherapeutic Drugs"Alzheimer's Disease: Selections from "The World Market for Neurotherapeutic Drugs"AntibioticsJapan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs MarketAntibacterial Drugs: World Market Prospects 2012-2022Development of New Antibiotics Hits a Road BlockAnti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials MarketAntibacterial Drugs: Commercial Prospects 2011-2026The 2011-2016 World Outlook for Sulfonamide Pharmaceuticals Excluding Sulfa-Antibiotic CombinationsThe 2011-2016 World Outlook for Topical Antibiotic PharmaceuticalsAnti-Infective Drugs MarketsThe World Market for Penicillins and Derivatives with a Penicillanic Acid Structure and Salts Thereof: A 2011 Global Trade PerspectiveAntibiotic Resistance and Antibiotic Technologies: Global MarketsChinese Markets for AntibioticsThe World Market for Medicaments Containing Hormones, Their Derivatives, and Other Steriods Used as Hormones Excluding Antibiotics and Their Derivatives: A 2011 Global Trade PerspectiveAntibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial IncentiveChinese Markets for CephalosporinsChinese Markets for PenicillinAnalysis Report on China Antibiotic IndustryConference Documentation: Superbugs & Superdrugs - A Focus on AntimicrobialsThe Global Market for Antimicrobials and Antifungals: Challenging Resistance to 2016Strategic Review of the European Ban of Antibiotic Growth Promoters in Animal FeedU.S. Critical Care Antibiotics MarketsAntibiotic Resistance: New Products and StrategiesMarketLooks: The U.S. Market for PenicillinAnti-Obesity DrugsWorld Anti-Obesity Drug Market 2011-2021Global Anti-Obesity Treatments Market 2010-2025Chinese Markets for Anti-Obesity DrugsThe World Diabetes Market, 2007-2025: An analysis of Diabetes Drug and Insulin MarketU.S. Anti-obesity Prescription MarketsWorld Emerging Anti-Obesity Prescription Drug MarketsProstate Cancer TherapeuticsTriple Analysis: Colorectal Cancer, Prostate Cancer and AngiogenesisHormone Refractory Prostate Cancer - Pipeline Review, H2 2011Global Prostate Cancer Therapeutics Market (2010 - 2020) (Opportunity Analysis, Pipeline Assessment & Market Forecast)Prostate Cancer - Pipeline Review, H2 2011Prostate Cancer - US Drug Forecasts and Treatment Analysis to 2020A Decision Support Tool for Optimizing the Cancer Pipeline Portfolio. From Research and Development to Market.Triple Analysis: Breast Cancer, Prostate Cancer and Protein Kinase InhibitorsProstate Cancer Drug Discoveries: What the Future HoldsProstate Cancer - A Therapeutic & Competitive InsightU.S. Emerging Prostate Cancer Therapeutics MarketsAntiviralsChemotherapy-Induced Neutropenia (CIN) Therapeutics -Pipeline Assessment and Market Forecasts to 2018U.S. Hepatitis C MarketVictrelis (boceprevir) - First-in-Class Oral Hepatitis C Virus (HCV) Protease Inhibitor Approved in The US and Telaprevir to FollowTelaprevir and Boceprevir: The First Generation Protease Inhibitors Boosts Response Rates to Standard Chronic Hepatitis C TreatmentR&D Trends: Hepatitis CCommercial Insight: Hepatitis B in ChinaAntivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C MarketsBrief: Hepatitis C/AASLD 2010Forecast Insight: Hepatitis B - Baraclude and Viread set to thrive in the face of limited competitionHIV - AIDS Therapeutics - Pipeline Assessment and Market Forecasts to 2017Pricing and Reimbursement of AntiviralsThe Antivirals Pipeline: Competitive ReviewThe Worldwide Market for Prescription Dermatological Drugs, 7th EditionDealmaking and Industry Outlook: AntiviralsGlobal Antivirals Market 2010-2025Antivirals: Novel Targets, Technologies, and DealmakingHepatitis C Therapeutics Market - ThailandProtease Inhibitors: Innovation Drives Drug PipelineThe Global Antivirals Market: R&D Pipelines, Market Analysis and Competitive LandscapeThe World Market for Anti-infectives Series: Volumes I - III - Antifungals, Antibacterials and AntiviralsU.S. HIV/AIDS Therapies MarketsMarket for Antiviral Therapeutics and VaccinesMarket For Gene Therapy and Antisense DrugsPrescription DrugsWorld Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)Japan Pharmaceutical Industry & Forecast-Focus on OTC and Prescription Drugs MarketPharmaceutical Key Trends 2011 - Prescription Pharmaceutical Sales OverviewWorld Market for Prescription Generic Drugs, 6th EditionPrescription Dermatological Drugs: Worldwide Market, 6th EditionHerbal Supplements, Prescription Drugs, Rx-to-OTC Products: A ComparisonThe World Market for Prescription Respiratory DrugsThe World Market for Prescription Gastrointestinal DrugsThe Worldwide Market for Prescription Dermatological Drugs, 5th EditionThe Worldwide Market for Prescription Cardiovascular DrugsMedicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003The Worldwide Market for Prescription Dermatological Drugs - 4th EditionThe Worldwide Prescription Drug Market 2004World Emerging Anti-Obesity Prescription Drug MarketsThe Worldwide Market for Prescription Generic Drugs- 4th EditionThe Market for Prescription Antiviral DrugsDirect-to-consumer Advertising & Prescription Drug PromotionU.S. Antifungal Prescription Pharmaceutical MarketsAutoimmune Disease TherapeuticsOrphan Autoimmune Disorders to 2017 - Strong Performance by Nplate and Promacta and Future Launches of Immunoglobulin Therapies will Drive the ITP MarketRheumatoid Arthritis Therapeutics - Pipeline Assessment and Market Forecasts to 2018Global Multiple Sclerosis Drug Market 2010-2025The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deal AnalysisAutoimmune Disease Therapeutics to 2016Dealmaking and Industry Outlook: Autoimmune and Inflammatory DiseasesRheumatoid Arthritis Therapeutics Market in JapanEuropean Autoimmune Diseases Therapeutics MarketsBAFF (BLys) & APRIL: Emerging Targets For Autoimmune Disease & Cancer TherapeuticsAutoimmune Disorders & Transplant Rejection The Potential Of T-cells Targeted TherapeuticsMarket for Autoimmune Drugs and Disease ManagementCNS TherapeuticsCNS Lymphoma - Pipeline Review, H1 2012Pain Management Therapeutics Market to 2017 - Price Competition to Intensify Following Patent Expiries of Lyrica and CymbaltaCentral Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals AnalysisThe Global Market for Pain Management Drugs and DevicesInhaled CNS TherapeuticsThe Global Market for Pain Management Drugs and DevicesCNS Market Trends, 2007 to 2010The World Market for Pain Management Drugs and Devices, 2nd EditionEuropean Central Nervous System (CNS) Therapeutics MarketsThe World Market for Pain Management Drugs and Devices: Applications and Top ProductsMultiple Myeloma TherapeuticsMultiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Multiple Myeloma - Pipeline Review, Q3 2011Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018Multiple Myeloma Global Clinical Trials Review, Q4, 2010U.S. Multiple Myeloma MarketHepatitis C Virus And TherapeuticsHepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016Key Companies: HCV - New market entrants are changing the corporate landscapeGlobal Hepatitis C Virus (HCV) Market- An AnalysisCompetitive Outlook on HCV: What to Know & Expect in R&D and Business DevelopmentLung Cancer TherapeuticsSmall-Cell Lung Cancer - Pipeline Review, H1 2012Triple Analysis: Lung Cancer, Prostate Cancer and AngiogenesisTriple Analysis: Lung Cancer, Apoptosis and AntibodiesLung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 CountriesNon-Small Cell Lung Cancer (NSCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Non-Small Cell Lung Cancer - Pipeline Review, H2 2011Small Cell Lung Cancer (SCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Non-small Cell Lung Cancer Drug Market in South KoreaLung Cancer Therapeutics Market Outlook and Pipeline AnalysisCompetitive Outlook on Lung Cancer Drug Development - The Missing Handbook to New Product Planning and Portfolio PlanningLung Cancer Drug Discoveries : what the future holdsChinese Markets for Lung Cancer Treatment DrugsTargeted Therapeutics in Non-Small Cell Lung CancerCurrent and Future Therapies for Lung Cancer - A Therapeutic & Competitive InsightRadiopharmaceuticalsGlobal Nuclear Medicine (Medical Isotopes/ Radioisotopes/ Radiopharmaceuticals) Market in PET/SPECT Imaging and Therapy - Competitive Landscape, Current trends and Forecasts (2010 - 2015)Nuclear Cardiology MarketsUS Markets for Contrast Agents and Radiopharmaceuticals 2011Special Report: State of the Pharmaceutical Industry, 2010-Critical Role of Midsize PharmaMedical Imaging Markets: Contrast AgentsBiologic Imaging Reagents: Technologies and Global MarketsMedical Imaging (Equipment, Agents & Consumables) to 2010The European Contrast Media and Radiopharmaceuticals MarketsU.S. Radiopharmaceuticals MarketsDecubitus Ulcer Treatment ProductsWorld Wound Care Markets 2010Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th EditionWound Care Markets, 4th. Edition, Vol. I: Skin UlcersWorld Wound Care Markets 2008 (Sales and Key Trends in the Treatment of Burns, Skin Ulcers, Surgical and Trauma Wounds)Medical Beds Worldwide, Therapeutic Surfaces WorldwideWound Care Markets, 3rd. Edition, Vol. I: Skin UlcersWound Care Markets Volume I: Skin UlcersMonoclonal Antibody Based ProductsIndian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies), 4th EditionTherapeutic Monoclonal Antibodies: World Market 2011-2021Therapeutic Proteins Market to 2017 - High Demand for Monoclonal Antibodies will Drive the MarketAdvanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production TechnologiesThe Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals AnalysisTherapeutic Monoclonal Antibodies MarketsProtein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global MarketTherapeutic Monoclonal Antibodies Report 2008-2023Monoclonal Therapeutics and Companion Diagnostic ProductsTherapeutic Monoclonal Antibodies, 2006-2011 - Maximising the Growth Potential of a Stocked PipelineMonoclonal Antibodies in Cancer Therapy: Emerging Products and MarketsDynamic Antibody Industry, Including Polyclonals and MonoclonalsLou Gehrig's DiseaseNeurodegenerative Disease Market to 2017 - Patent Expiries of High Selling Drugs Such as Aricept, Namenda, Avonex, Rebif and Copaxone will Restrain GrowthAmyotrophic Lateral Sclerosis (ALS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018Lou Gehrig Disease Report - Is there a link between Lipitor and ALS?Bladder Cancer TherapeuticsBladder Cancer - Pipeline Review, H2 2011The Worldwide Market for Cancer Diagnostics, 4th EditionChinese Markets for Bladder Cancer Treatment DrugsStakeholder Opinions: Bladder Cancer - New drugs needed to challenge ineffective 20-year old drugs, 2008Superficial Bladder Cancer - Current Mangement and Future TrendsAnti-Hypertensive DrugsAntihypertensives Market to 2016 - Generic Erosion Following Patent Expiry of Major ARBs to Impact the MarketGlobal Cardiovascular Drugs Market 2009-2024The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)The World Hypertension Market 2007-2023Innovations in Cardiovascular Disease ManagementCardiovascular Pharmaceutical Market Trends, 2007 to 2010 - Key Market Forecasts and Growth OpportunitiesThe Worldwide Market for Prescription Cardiovascular DrugsAnti-Migraine DrugsMigraine - Pipeline Review, H2 2011Migraine Global Clinical Trials Review, Q1, 2011Pipeline and Commercial Insight: Migraine - Challenges ahead for first-in-class developmentsMigraine Market ForecastMigraine (Acute): Neurologists’ Expectations for a New Acute Therapy Extend Beyond Cardiovascular SafetyThe Anti-Migraine Market 2007-2022Outlook for the Migraine Market With Novel Approaches Limited, Triptans DominateAnti-InfectivesAnti-Infectives and Antimicrobials Review and Outlook 2011Molecular Diagnostics in Infectious Disease TestingENT Disorders Market to 2016 - Increasing Resistance to Anti-Bacterials to Drive Development of Novel Therapies for ENT DisordersAnti-Bacterials Market to 2016 - Cephalosporins, Penicillins, Macrolides and Fluoroquinolones to Drive the Anti-Bacterials MarketAntifungal Drugs: Technologies and Global MarketsAnimal Health Products Antibacterials MarketsAnti-Infectives: World Market, 2nd. Ed., Vol. I: AntifungalsThe U.S. Market for Over-the-Counter Anti-InfectivesThe World Market for Anti-Fungal TherapiesThe World Market for Anti-infectives Series: Volumes I - III - Antifungals, Antibacterials and AntiviralsThe Market for Antifungal DrugsAnti-Infectives 2002MarketLooks: The U.S. Market for Anti-infective, Antifungal, Antipruritic Rx-to-OTC SwitchesU.S. Antifungal Prescription Pharmaceutical MarketsU.S. and European Markets for AntifungalsErectile Dysfunction Drugs